Terminal deoxynucleotidyl transferase (TdT)-containing peripheral blood mononuclear cells during remission of acute lymphoblastic leukemia: low sensitivity and specificity prevent accurate prediction of relapse

Leuk Res. 1987;11(6):537-43. doi: 10.1016/0145-2126(87)90089-0.

Abstract

Serial samples of peripheral blood were obtained from 75 children with acute lymphoblastic leukemia in remission. An immunofluorescence assay was used to quantitate TdT-containing (terminal deoxynucleotidyl transferase-containing) cells in the mononuclear leukocyte fraction of these specimens. Nine relapses in 8 patients were preceded by elevations (0.12-0.70%) in peripheral blood terminal deoxynucleotidyl transferase-containing cells noted 1-33 weeks prior to relapse. No such elevations were observed prior to 6 relapses in 4 patients. Peripheral blood terminal transferase deoxynucleotidyl-containing cells were elevated (0.12-0.61%) in 22 children who did not relapse over a 5-82 week period of observation. The sensitivity (67%) and specificity (68%) of this assay are inadequate to establish which patients have minimal residual leukemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • DNA Nucleotidylexotransferase / blood*
  • DNA Nucleotidyltransferases / blood*
  • Female
  • Humans
  • Leukemia, Lymphoid / blood
  • Leukemia, Lymphoid / enzymology*
  • Male
  • Methods
  • Monocytes / enzymology*

Substances

  • DNA Nucleotidyltransferases
  • DNA Nucleotidylexotransferase